PAR 24.4% 25.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,381 Posts.
    lightbulb Created with Sketch. 6924
    Agreed....this is the official start...it will brew away nicely in the background, we will need to be patient...but the magic of this is that no one knows what will strike and when.

    A deal, though it will take some effort and a heap of time, can actually happen any time.

    The next goal now is Read-out and then Registration (in terms of P3 OA), a ways off...but it will be a big milestone.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.